Evidence map›Paper›PMID 41357630›Full record

ArticleWorld journal of gastrointestinal surgery2025

Clinicopathological features of patients undergoing surgery for pancreatic cancer with very early postoperative recurrence.

Hüseyin Fahri Martlı, Hüseyin Oytun İnsan, Mert Altaş, Betül Erişmiş, Velihan Çayhan, Osman Ersoy, Mehmet Keşkek, Mesut Tez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hüseyin Fahri MartlıDepartment of General Surgery, Ankara City Hospital, Ankara 06800, Türkiye.
Hüseyin Oytun İnsanDepartment of Surgery, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.
Mert AltaşDepartment of Surgery, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.
Betül ErişmişDepartment of Internal Medicine, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.
Velihan ÇayhanDepartment of Radiology, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.
Osman ErsoyDepartment of Gastroenterology, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.
Mehmet KeşkekDepartment of General Surgery, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.
Mesut TezDepartment of Surgery, University of Health Sciences, Ankara City Hospital, Ankara 06800, Türkiye. mesuttez@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy, with approximately 50% of patients experiencing recurrence within 1-year post-surgery. Very early recurrence (VER), defined as recurrence within 12 weeks, is an emerging concept.

aimTo investigate clinicopathological characteristics and predictive factors for VER in patients with PDAC.

methodsA retrospective cohort study was conducted on 553 patients who underwent pancreatic surgery for PDAC at a single high-volume center between February 2019 and December 2024. Patients with VER (group 1,

resultsGroup 1 patients were younger (65 ± 16.85 years

conclusionPoorly differentiated tumors are a key predictor of VER, linked to higher mortality. Machine learning enhances predictive accuracy, and molecular studies are needed to elucidate VER mechanisms. Tailored surveillance and multi-institutional validation are recommended.

Indexed as

Machine learningPancreatic ductal adenocarcinomaPoorly differentiated tumorsRed cell distribution widthTumor locationVery early recurrence

Identifiers

PMID41357630
PMCPMC12679014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.